ProtoKinetix' Synthetic Antifreeze Glycoprotein is Now Trademarked as AAGP
September 21, 2005 11:48 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Sept. 21, 2005 (PRIMEZONE) -- After extensive testing by ProtoKinetix, Inc. (OTCBB:PKTX) on a wide range of cells and tissue, the Company has determined that their...
Increased Concentrations of ProtoKinetix's Synthetic AFGP Dramatically Slows Aging Process on Skin Cells
September 07, 2005 10:49 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Sept. 7, 2005 (PRIMEZONE) -- Results just received clearly confirm that in the presence of ProtoKinetix's (OTCBB:PKTX) synthetic antifreeze glycoprotein (AFGP), the aging...
ProtoKinetix Receives Remarkable Results from Study Using Synthetic AFGP on Skin Cells
August 25, 2005 11:27 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Aug. 25, 2005 (PRIMEZONE) -- Dr. John Todd, president and CEO of ProtoKinetix, Inc. (OTCBB:PKTX) announces today the results of the in-vitro effect of their synthetic...
ProtoKinetix Commences Organ Preservation Trials
August 23, 2005 07:00 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Aug. 23, 2005 (PRIMEZONE) -- Following PKTX's (OTCBB:PKTX) successful testing of AFGP on heart cells announced July 18, 2005, the Company has just completed their initial...
ProtoKinetix Announces Commercialization Strategy for AFGP
July 27, 2005 12:27 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, July 27, 2005 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) management has identified the first three product lines ready for commercial development. This family of...
Higher Concentrations of ProtoKinetix's Synthetic AFGP Show Significant Increase in Heart Cell Survivability
July 18, 2005 10:48 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, July 18, 2005 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) announces that tests repeated by ProteoCell Biotechnologies, using higher concentrations of AFGP, in both...
Collaborative Agreement Reached with Premier Research Institution
July 14, 2005 12:05 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, July 14, 2005 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) announces a major collaborative agreement with one of the world's most prestigious blood specialty...
Survival of Sensitive Heart Cells After Freezing Shows Promise for Increased Organ Shelf Life
July 12, 2005 12:41 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, July 12, 2005 (PRIMEZONE) -- Dr. John Todd, President and CEO of ProtoKinetix, Inc. (OTCBB:PKTX), reports today on the Company's progress towards the commercialization of...
Second Generation Synthetic AFGP Tests Stable and Safe
May 19, 2005 07:00 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, May 19, 2005 (PRIMEZONE) -- The University of Rouen in France reports that their laboratory has completed an enzymatic study on the dimeric compound of synthetic AFGP,...
University of Rouen Laboratory Announces Completion Of Second Generation Synthetic AFGP
May 12, 2005 07:00 ET | ProtoKinetix, Incorporated
VANCOUVER, British Columbia, May 12, 2005 (PRIMEZONE) -- Dr. Geraldine Deliencourt, of the University of Rouen, has informed ProtoKinetix (OTCBB:PKTX) that their laboratory has completed the...